These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
382 related articles for article (PubMed ID: 23969019)
21. Immunopathogenesis of ophthalmological paraneoplastic syndromes: Recent findings. Kordyś M; Przeździecka-Dołyk J; Turno-Kręcicka A; Misiuk-Hojło M Adv Clin Exp Med; 2018 Oct; 27(10):1431-1439. PubMed ID: 30289210 [TBL] [Abstract][Full Text] [Related]
22. The potential role of plasma exchange as a treatment for bilateral diffuse uveal melanocytic proliferation: a report of two cases. Jaben EA; Pulido JS; Pittock S; Markovic S; Winters JL J Clin Apher; 2011 Dec; 26(6):356-61. PubMed ID: 21898575 [TBL] [Abstract][Full Text] [Related]
23. Non-paraneoplastic autoimmune retinopathy that developed in fellow eye 10 years after onset in first eye: a case report. Miura G; Baba T; Iwase T; Ohde H; Kanda A; Saito W; Ishida S; Yamamoto S BMC Ophthalmol; 2020 Apr; 20(1):132. PubMed ID: 32252709 [TBL] [Abstract][Full Text] [Related]
24. Unusual paraneoplastic cause of vision loss: combined paraneoplastic cone dystrophy and optic neuropathy. Finger ML; Thirkill CE; Borruat FX Arch Ophthalmol; 2012 May; 130(5):660-2. PubMed ID: 22652860 [No Abstract] [Full Text] [Related]
25. [Ocular manifestations of cancer]. De Potter P; Disneur D; Levecq L; Snyers B J Fr Ophtalmol; 2002 Feb; 25(2):194-202. PubMed ID: 11941243 [TBL] [Abstract][Full Text] [Related]
26. Ocular Paraneoplastic Syndromes. Przeździecka-Dołyk J; Brzecka A; Ejma M; Misiuk-Hojło M; Torres Solis LF; Solís Herrera A; Somasundaram SG; Kirkland CE; Aliev G Biomedicines; 2020 Nov; 8(11):. PubMed ID: 33182708 [TBL] [Abstract][Full Text] [Related]
27. Bilateral paraneoplastic optic neuropathy and unilateral retinal compromise in association with prostate cancer: a differential diagnostic challenge in a patient with unexplained visual loss. Carboni G; Forma G; Bond AD; Adamus G; Iannaccone A Doc Ophthalmol; 2012 Aug; 125(1):63-70. PubMed ID: 22569848 [TBL] [Abstract][Full Text] [Related]
34. PARANEOPLASTIC VITELLIFORM MACULOPATHY IN THE SETTING OF CHOROIDAL MELANOMA: EVOLUTION OVER ONE YEAR. Nagiel A; Rootman DB; McCannel TA Retin Cases Brief Rep; 2017 Winter; 11 Suppl 1():S7-S10. PubMed ID: 27533643 [TBL] [Abstract][Full Text] [Related]
35. Distinct clinical characteristics of paraneoplastic optic neuropathy. Xu Q; Du W; Zhou H; Zhang X; Liu H; Song H; Wang X; Wei S Br J Ophthalmol; 2019 Jun; 103(6):797-801. PubMed ID: 30021813 [TBL] [Abstract][Full Text] [Related]
36. [Paraneoplastic retinopathy]. Liu Y; Lei B Zhonghua Yan Ke Za Zhi; 2012 Jul; 48(7):653-6. PubMed ID: 22943872 [TBL] [Abstract][Full Text] [Related]
37. Autoantibody against transient receptor potential M1 cation channels of retinal ON bipolar cells in paraneoplastic vitelliform retinopathy. Wang Y; Abu-Asab MS; Li W; Aronow ME; Singh AD; Chan CC BMC Ophthalmol; 2012 Nov; 12():56. PubMed ID: 23148706 [TBL] [Abstract][Full Text] [Related]